| Target Price | $102.00 |
| Price | $87.09 |
| Potential |
17.12%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Medtronic 2027 .
The average Medtronic target price is $102.00.
This is
17.12%
register free of charge
$127.05
45.88%
register free of charge
$78.78
9.54%
register free of charge
|
|
| A rating was issued by 34 analysts: 23 Analysts recommend Medtronic to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medtronic stock has an average upside potential 2027 of
17.12%
register free of charge
|
| Apr '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 36.36 | 39.46 |
| 8.43% | 8.50% | |
| EBITDA Margin | 24.49% | 28.17% |
| 2.00% | 15.01% | |
| Net Margin | 13.20% | 19.49% |
| 5.02% | 47.62% |
32 Analysts have issued a sales forecast Medtronic 2027 . The average Medtronic sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Medtronic EBITDA forecast 2027. The average Medtronic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
32 Medtronic Analysts have issued a net profit forecast 2027. The average Medtronic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Apr '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.73 | 6.01 |
| 3.32% | 61.13% | |
| P/E | 14.49 | |
| EV/Sales | 3.30 |
32 Analysts have issued a Medtronic forecast for earnings per share. The average Medtronic EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Sep 02 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


